Changes in weight after switching to dolutegravir containing antiretroviral therapy in the Swiss HIV cohort study

被引:0
|
作者
Mugglin, C. [1 ]
Calmy, A. [2 ]
Guenthard, H. [3 ]
Tarr, P. [4 ]
Atkinson, A. [1 ]
Scherrer, A. [5 ,6 ]
Cavassini, M. [7 ,8 ]
Marzolini, C. [9 ,10 ,11 ]
Schmid, P. [12 ]
Bernasconi, E. [13 ]
Braun, D. [5 ,6 ]
Wandeler, G. [1 ]
Rauch, A. [1 ]
机构
[1] Univ Bern, Bern Univ Hosp, Dept Infect Dis, Bern, Switzerland
[2] Geneva Univ Hosp, Div Infect Dis, Geneva, Switzerland
[3] Univ Hosp Zurich, Div Infect Dis & Hosp Epidemiol, Zurich, Switzerland
[4] Univ Basel, Kantonsspital Baselland, Dept Med & Infect Dis Serv, Bruderholz, Switzerland
[5] Univ Hosp Zurich, Zurich, Switzerland
[6] Univ Zurich, Div Infect Dis & Hosp Epidemiol, Zurich, Switzerland
[7] Lausanne Univ Hosp, Lausanne, Switzerland
[8] Univ Lausanne, Serv Infect Dis, Lausanne, Switzerland
[9] Univ Hosp Basel, Basel, Switzerland
[10] Univ Basel, Dept Med, Div Infect Dis & Hosp Epidemiol, Basel, Switzerland
[11] Univ Basel, Dept Clin Res, Div Infect Dis & Hosp Epidemiol, Basel, Switzerland
[12] Cantonal Hosp St Gallen, Div Infect Dis & Hosp Epidemiol, St Gallen, Switzerland
[13] Reg Hosp Lugano, Div Infect Dis, Lugano, Switzerland
关键词
D O I
暂无
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
PS3/5
引用
收藏
页码:9 / 9
页数:1
相关论文
共 50 条
  • [41] Simplification to dual therapy containing lamivudine and raltegravir or dolutegravir in HIV-infected patients on virologically suppressive antiretroviral therapy
    Calza, Leonardo
    Colangeli, Vincenzo
    Borderi, Marco
    Testi, Diletta
    Granozzi, Bianca
    Bon, Isabella
    Re, Maria Carla
    Viale, Pierluigi
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2020, 75 (11) : 3327 - 3333
  • [42] Switching to an integrase inhibitor containing antiretroviral regimen is not associated with above-average weight gain in middle-aged people living with HIV on long-term suppressive antiretroviral therapy, the AGEhIV cohort study
    Verboeket, S.
    Boyd, A.
    Wit, F.
    Verheij, E.
    van der Loeff, M. Schim
    Kootstra, N.
    van der Valk, M.
    Reiss, P.
    HIV MEDICINE, 2019, 20 : 9 - 10
  • [43] Stable partnership and progression to AIDS or death in HIV infected patients receiving highly active antiretroviral therapy: Swiss HIV cohort study
    Young, J
    De Geest, S
    Spirig, R
    Flepp, M
    Rickenbach, M
    Furrer, H
    Bernasconi, E
    Hirschel, B
    Telenti, A
    Vernazza, P
    Battegay, M
    Bucher, HC
    BRITISH MEDICAL JOURNAL, 2004, 328 (7430): : 15 - 18B
  • [44] Association of non-adherence to antiretroviral therapy with cardiovascular outcomes in virologically suppressed persons living with HIV: the Swiss HIV Cohort Study
    Castillo-Mancilla, J.
    Cavassini, M.
    Schneider, M-P
    Furrer, H.
    Calmy, A.
    Battegay, M.
    Scanferla, G.
    Bernasconi, E.
    Gunthard, H.
    Glass, T. R.
    HIV MEDICINE, 2019, 20 : 202 - 202
  • [45] Weight changes after first-line antiretroviral initiation in a cohort of HIV-positive patients in Southern Spain (CAPOTA study)
    Gomez-Ayerbe, Cristina
    Palacios, Rosario
    Mayorga, Marisa
    Nicolas Navarrete, Miguel
    Ferra, Sergio
    Ruiz, Inmaculada
    Garcia, Coral
    Castano, Manuel
    Merino, Dolores
    Collado, Antonio
    Hidalgo-Tenorio, Carmen
    Delgado, Marcial
    Rivero, Antonio
    Santos, Jesus
    INTERNATIONAL JOURNAL OF STD & AIDS, 2022, 33 (13) : 1119 - 1123
  • [46] Weight and Metabolic Changes After Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in People Living With HIV A Cohort Study
    Surial, Bernard
    Mugglin, Catrina
    Calmy, Alexandra
    Cavassini, Matthias
    Gunthard, Huldrych F.
    Stockle, Marcel
    Bernasconi, Enos
    Schmid, Patrick
    Tarr, Philip E.
    Furrer, Hansjakob
    Ledergerber, Bruno
    Wandeler, Gilles
    Rauch, Andri
    ANNALS OF INTERNAL MEDICINE, 2021, 174 (06) : 758 - +
  • [47] Swiss HIV Cohort Study
    不详
    AIDS PATIENT CARE AND STDS, 1999, 13 (06) : 376 - 376
  • [48] Changes in renal, bone, lipid, and inflammation markers in HIV-1 patients after combination antiretroviral therapy simplification to dolutegravir monotherapy
    Wijting, Ingeborg E. A.
    Rokx, Casper
    Zillikens, Maria C.
    Smits, Sandra A. A.
    de Vries-Sluijs, Theodora E. M. S.
    Schurink, Carolina A. M.
    Bax, Hannelore I.
    van der Ende, Marchina E.
    van Gorp, Eric C. M.
    Nouwen, Jan L.
    Verbon, Annelies
    Bierman, Wouter F. W.
    Rijnders, Bart J. A.
    INTERNATIONAL JOURNAL OF STD & AIDS, 2019, 30 (11) : 1042 - 1048
  • [49] Emergence of Drug Resistance in the Swiss HIV Cohort Study Under Potent Antiretroviral Therapy Is Observed in Socially Disadvantaged Patients
    Abela, Irene A.
    Scherrer, Alexandra U.
    Boeni, Juerg
    Yerly, Sabine
    Klimkait, Thomas
    Perreau, Matthieu
    Hirsch, Hans H.
    Furrer, Hansjakob
    Calmy, Alexandra
    Schmid, Patrick
    Cavassini, Matthias
    Bernasconi, Enos
    Guenthard, Huldrych F.
    Anagnostopoulos, A.
    Battegay, M.
    Bernasconi, E.
    Boni, J.
    Braun, D. L.
    Bucher, H. C.
    Calmy, A.
    Cavassini, M.
    Ciuffi, A.
    Dollenmaier, G.
    Egger, M.
    Elzi, L.
    Fehr, J.
    Fellay, J.
    Furrer, H.
    Fux, C. A.
    Gunthard, H. F.
    Haerry, D.
    Hasse, B.
    Hirsch, H. H.
    Hoffmann, M.
    Hosli, I
    Huber, M.
    Kahlert, C.
    Kaiser, L.
    Keiser, O.
    Klimkait, T.
    Kouyos, R. D.
    Kovari, H.
    Ledergerber, B.
    Martinetti, G.
    de Tejada, Martinez B.
    Marzolini, C.
    Metzner, K. J.
    Mueller, N.
    Nicca, D.
    Paioni, P.
    CLINICAL INFECTIOUS DISEASES, 2020, 70 (02) : 297 - 303
  • [50] Hepatitis B Virus Infection Is Associated With Impaired Immunological Recovery During Antiretroviral Therapy in the Swiss HIV Cohort Study
    Wandeler, Gilles
    Gsponer, Thomas
    Bihl, Florian
    Bernasconi, Enos
    Cavassini, Matthias
    Kovari, Helen
    Schmid, Patrick
    Battegay, Manuel
    Calmy, Alexandra
    Egger, Matthias
    Furrer, Hansjakob
    Rauch, Andri
    JOURNAL OF INFECTIOUS DISEASES, 2013, 208 (09): : 1454 - 1458